Grey Matter Neurosciences
PrivateLast Round
Seed
Dec 1, 2024
Total Funding Raised
$14M
Momentum Score
25 /100
Company Overview
Grey Matter Neurosciences is a medical technology company developing revolutionary medical devices and drug-device combinations to treat age-related diseases of the brain.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Mental Health, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Grey Matter Neurosciences Comps
Public and private peers based on sector, stage, and business model.
Grey Matter Neurosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 1, 2024 |
Grey Matter Neurosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ontario Brain Institute | Seed |
| TIAP | Seed |
| Wittington Innovation Fund | Seed |
| Weston Family Foundation | Seed |
| Ontario Centre of Innovation | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Monthly visitors grew 133% MoM, reaching 1.8K.
- Oct 13, 2025
Grew 25% QoQ, from 16 to 20 employees.
Grey Matter Neurosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Grey Matter Neurosciences's valuation, stock price, and market status.
